Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 10:11 AM ET

Date/Time Source News Release
06/06/2025 08:00 AM EDT Newsfile PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value
11/15/2024 05:30 PM EST Newsfile PharmaDrug Announces Issuance of Debenture Units
10/31/2024 05:55 PM EDT Newsfile PharmaDrug Announces Proposed Issuance of Debenture Units
10/31/2024 08:58 AM EDT Newsfile PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases
09/19/2024 08:00 AM EDT Newsfile PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases
08/28/2024 08:00 AM EDT Newsfile PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases
08/21/2024 10:14 AM EDT GlobeNewswire PharmaTher's Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins
08/21/2024 09:52 AM EDT Newsfile PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins
08/19/2024 08:00 AM EDT GlobeNewswire PharmaTher's Sairiyo Therapeutics Receives Approval to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)
05/23/2024 08:00 AM EDT Newsfile Pharmadrug's Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade Cocaine
Page

Additional News

As of June 13, 2025 • 10:11 AM ET

Date/Time Source News Release
10/11/2024 10:01 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Fri, Oct 11, 2024 as of 10.00 am ET
09/11/2024 10:00 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Wed, Sep 11, 2024 as of 10.00 am ET
08/19/2024 08:00 AM EDT Invezz PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine
08/16/2024 04:30 PM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Evening edition
Fri, Aug 16, 2024 as of 4:00 pm ET
08/16/2024 10:00 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Fri, Aug 16, 2024 as of 10.00 am ET
08/15/2024 04:30 PM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Evening edition
Thu, Aug 15, 2024 as of 4:00 pm ET
08/06/2024 10:00 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Tue, Aug 06, 2024 as of 10.00 am ET
07/31/2024 04:30 PM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Evening edition
Wed, Jul 31, 2024 as of 4:00 pm ET
07/18/2024 10:00 AM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Morning edition
Thu, Jul 18, 2024 as of 10.00 am ET
07/10/2024 04:30 PM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Evening edition
Wed, Jul 10, 2024 as of 4:00 pm ET
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.